SevenBridge Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $221K | Sell |
397
-145
| -27% | -$80.7K | 0.04% | 203 |
|
|
2025
Q1 | $312K | Sell |
542
-121
| -18% | -$69.7K | 0.06% | 181 |
|
|
2024
Q4 | $441K | Sell |
663
-58
| -8% | -$38.6K | 0.08% | 154 |
|
|
2024
Q3 | $595K | Sell |
721
-10
| -1% | -$8.26K | 0.11% | 129 |
|
|
2024
Q2 | $779K | Sell |
731
-10
| -1% | -$10.7K | 0.17% | 116 |
|
|
2024
Q1 | $709K | Sell |
741
-155
| -17% | -$148K | 0.16% | 117 |
|
|
2023
Q4 | $787K | Sell |
896
-13
| -1% | -$11.4K | 0.19% | 107 |
|
|
2023
Q3 | $748K | Sell |
909
-56
| -6% | -$46.1K | 0.19% | 106 |
|
|
2023
Q2 | $693K | Hold |
965
| – | – | 0.18% | 109 |
|
|
2023
Q1 | $793K | Hold |
965
| – | – | 0.22% | 102 |
|
|
2022
Q4 | $696K | Hold |
965
| – | – | 0.2% | 106 |
|
|
2022
Q3 | $665K | Hold |
965
| – | – | 0.23% | 95 |
|
|
2022
Q2 | $570K | Sell |
965
-422
| -30% | -$249K | 0.23% | 89 |
|
|
2022
Q1 | $969K | Sell |
1,387
-71
| -5% | -$49.6K | 0.34% | 70 |
|
|
2021
Q4 | $921K | Buy |
1,458
+542
| +59% | +$342K | 0.28% | 86 |
|
|
2021
Q3 | $554K | Buy |
916
+55
| +6% | +$33.3K | 0.18% | 103 |
|
|
2021
Q2 | $481K | Buy |
861
+187
| +28% | +$104K | 0.16% | 111 |
|
|
2021
Q1 | $319K | Buy |
+674
| New | +$319K | 0.12% | 119 |
|
|
2019
Q3 | – | Sell |
-75
| Closed | -$23K | – | 466 |
|
|
2019
Q2 | $23K | Hold |
75
| – | – | 0.01% | 361 |
|
|
2019
Q1 | $31K | Hold |
75
| – | – | 0.01% | 283 |
|
|
2018
Q4 | $28K | Hold |
75
| – | – | 0.02% | 265 |
|
|
2018
Q3 | $30K | Hold |
75
| – | – | 0.02% | 292 |
|
|
2018
Q2 | $26K | Hold |
75
| – | – | 0.01% | 312 |
|
|
2018
Q1 | $26K | Hold |
75
| – | – | 0.01% | 322 |
|
|
2017
Q4 | $28K | Hold |
75
| – | – | 0.02% | 332 |
|
|
2017
Q3 | $34K | Hold |
75
| – | – | 0.02% | 303 |
|
|
2017
Q2 | $37K | Sell |
75
-75
| -50% | -$37K | 0.02% | 304 |
|
|
2017
Q1 | $57K | Hold |
150
| – | – | 0.04% | 233 |
|
|
2016
Q4 | $56K | Hold |
150
| – | – | 0.04% | 238 |
|
|
2016
Q3 | $56K | Hold |
150
| – | – | 0.04% | 235 |
|
|
2016
Q2 | $52K | Buy |
+150
| New | +$52K | 0.04% | 264 |
|